TruthArchive.ai - Related Video Feed

First, the mRNA is injected within lipid nanoparticles in your arm. It travels through every organ system, including the heart. There are two papers, one by Baumeyer and colleagues, one by Crosson and colleagues. Crosson found mRNA directly in the heart of deceased mRNA recipients. So we know it reaches the heart. Baumeyer found the spike protein directly in the heart in biopsies of patients with vaccine induced myocarditis. So we know the vaccine mRNA and lipid nanoparticles get into the heart, translate into spike proteins, so your cardiomyocytes begin to produce a toxic non human protein and your own body attacks the heart resulting in inflammation and cardiac scarring including micro scars which are undetectable with imaging. You can only detect it with a microscope, which is very disturbing. And so once you have this scarring, you're going to have cardiac electrical abnormalities, electrical conduction abnormalities, and your heart's not going to beat properly. Then when you go exercise, we found there's two triggers either during exercise or sports when there's exertion or during the morning waking hours of sleep. In these two periods of time, there's a surge in catecholamines including dopamine, norepinephrine, and epinephrine. And so during these times when you have this cardiac damage, you have this scarring, that's the trigger you do that leads to this vaccine induced cardiac arrest. And that's why we saw a lot of sudden deaths among athletes back in 2021.

Myocarditis, or heart damage, is more common than previously thought. Studies in the US military and Thailand show that around 20% of people who receive the COVID vaccine develop myocarditis, as confirmed by echocardiograms and other tests. This means that out of every 1 million vaccinated individuals, 200,000 will experience heart damage. Unfortunately, 50% of those with myocarditis will die within 5 years. This alarming increase in myocarditis cases is due to the cardiotoxic nature of the vaccine. This information comes from Dr. Cressel and Shoemaker in Toronto, Canada.

Speaker 1 discusses the progression of understanding around heart damage associated with this product, emphasizing key studies and their implications. He recalls that in 2022 German scientists tested and reported that heart damage seen in myocarditis patients corresponds to vaccine-triggered autoimmune reactions. They examined endomyocardial biopsies and observed that the cardiac detection of the spike protein and CD4+ T cell–dominated inflammation suggested a vaccine-triggered autoimmune process. He notes headlines that infections could cause more myocarditis than vaccination and cites a large Israeli population study from that year finding no increase in myocarditis or pericarditis among unvaccinated individuals, challenging the notion that vaccination is the sole driver. Speaker 1 then highlights a new study published in the American Heart Association journal Circulation, framing it as a major development not from fringe sources but from a prestigious, mainstream journal. He asserts that this study goes beyond epidemiology by demonstrating a mechanism. In an experimental model, mice were used to induce myocarditis-like cardiac damage; researchers then compared these findings to humans who had similar heart damage post-vaccination. They found that T cells from patients with acute myopericarditis recognize vaccine-encoded spike epitopes that are homologous to cardiac self proteins, indicating cross-reactivity where the immune system targets both the spike protein and cardiac proteins. Speaker 1 explains that the study measured functional responses to potassium channels (KV) and observed an expanded pattern of cytokine production in patients with mild pericarditis after mRNA vaccination, but not in patients with COVID-19 without vaccination. This expanded cytokine response mirrored what was seen in AMP (myopericarditis) mice and in autoimmune myocarditis, linking the clinical data with the animal model. He paraphrases the study’s plain-language takeaway: post-mRNA vaccine myopericarditis is driven by molecular mimicry, with the immune system failing to distinguish self from non-self in susceptible patients. The study further notes that vaccine distribution contributes to susceptibility; the widespread distribution of the vaccine allows the heart to be targeted, leading to cardiac-selective autoimmunity by “heart-homing imprinting.” Speaker 1 emphasizes the significance of the source, stating that the journal is not fringe: it is the Circulation journal, ranked third in its field with a cardiovascular-focused impact in the 99th percentile. The overall conclusion presented is that these findings provide a clear mechanism for post-vaccination myopericarditis and establish a direct link between vaccine-encoded spike epitopes and cardiac autoimmunity.

The discussion centers on new evidence regarding myocarditis and pericarditis in the context of mRNA vaccination. It cites earlier 2022 German research showing that heart damage seen in myocarditis cases after vaccination may be a vaccine-triggered autoimmune reaction. The study analyzed endomyocardial biopsy samples and found that the cardiac tissue’s spike protein detection and CD4+ T cell–dominated inflammation suggested an autoimmune mechanism linking the vaccine to heart damage. This was contrasted with an Israel-based population study of hundreds of thousands of unvaccinated individuals that reported no increase in myocarditis or pericarditis incidence, highlighting a discrepancy with the vaccine-triggered autoimmune hypothesis. The center of the new claim is a study published in Circulation by the American Heart Association. The speakers emphasize the credibility of Circulation as a top cardiovascular journal. The study used an experimental mouse model to induce cardiac damage and then examined humans with similar heart damage after vaccination to see if the same mechanism applied. They report that T cells from patients with acute myopericarditis recognize vaccine-encoded spike epitopes that are homologous to cardiac self-proteins. In other words, the immune cells targeting the spike protein may also attack cardiac proteins due to molecular similarity. Further details from the study indicate that, in patients with mild pericarditis after mRNA vaccination (but not in those with COVID-19), there was an expanded pattern of cytokine production similar to that observed in myopericarditis–affected mice and in autoimmune myocarditis. The takeaway provided in plain language is that post-mRNA vaccine myopericarditis is driven by molecular mimicry, causing the immune system to fail to distinguish self from non-self in susceptible patients. The susceptibility is described as being influenced by the widespread distribution of the vaccine, which purportedly leads to heart-homing imprinting and a heart-targeted autoimmune response. The speakers stress that this journal is not fringe and highlight its high impact in cardiovascular medicine. They conclude that the data collectively suggest a mechanism by which the vaccine could provoke cardiac autoimmunity, with implications for clinical communication and understanding of post-vaccination myocarditis.

The discussion centers on evidence linking myocarditis and pericarditis to mRNA vaccination and the proposed mechanism behind it. It references a 2022 German study reporting that endomyocardial biopsy data from people with myocarditis showed cardiac detection of the spike protein and CD4+ T cell–dominated inflammation, suggesting a vaccine-triggered autoimmune reaction. The presenters note headlines at the time comparing myocarditis risk to infection, with claims that infection causes more myocarditis, and remind that vaccines were said not to stop transmission. They then cite a large Israeli population study from the same year involving subjects not vaccinated against SARS-CoV-2, which found no increase in the incidence of myocarditis or pericarditis, implying no observed vaccine-related signal in that cohort. Attention shifts to a more recent study published in Circulation by the American Heart Association, described as a high-impact, non-fringe journal, indicating a clearer mechanism has been demonstrated. The study described used an experimental mouse model to induce cardiac damage and then compared it to human cases with heart damage following vaccination. It states that T cells from patients with acute myocarditis or myopericarditis recognize vaccine-encoded spike epitopes that are homologous to cardiac self proteins, meaning the immune response to the spike protein can cross-react with heart tissues. The researchers further report that functional responses to potassium channels in patients with mild pericarditis after mRNA vaccination, but not in patients with COVID-19, showed an expanded pattern of cytokine production similar to that observed in myopericarditis mice and in autoimmune myocarditis. In plain terms, the summary of their takeaway is that post-mRNA vaccine myopericarditis is driven by molecular mimicry: the immune system cannot distinguish self from non-self, leading to an autoimmune attack on heart tissue in susceptible patients. The distribution of the vaccine (its widespread dissemination) is cited as a factor that makes patients susceptible by promoting heart-homing imprinting, effectively creating an anti-heart autoimmune response. The speakers emphasize that this Circulation article is a top-tier source, underscoring that the mechanism has been demonstrated with both animal models and human pathology, supporting the claim that the phenomenon has a defined immunological basis.

The speaker discusses a significant increase in myocarditis cases post-vaccination, with studies showing abnormal cardiac scans in vaccinated individuals. They suggest a potential link between mRNA vaccines and heart inflammation, emphasizing the need for long-term monitoring. Research indicates that mRNA and spike proteins can cause myocarditis, posing a concern for all mRNA products. The heart appears to be a vulnerable target due to various factors.

Heart inflammation, indicated by blue arrows, occurs after receiving a shot due to the presence of ACE2 receptors in the heart. This inflammation is caused by spike proteins from the shot, leading to the immune system attacking the heart tissues. The pericardium, the heart's surrounding sac, also experiences inflammation, as shown by the red arrows. Unfortunately, the heart cannot heal itself once damaged. The presence of blue dots signifies inflammation, while the gray area in the middle represents early scarring.

This vaccine has been widely used and is considered safe, with experience in over a billion people. While there is a very low risk of myocarditis, especially in young men, associated with the mRNA technology, the risk of getting myocarditis from COVID-19 itself is higher than the risk from the vaccine.

Before COVID-19, I only encountered two cases of myocarditis in my entire career as a cardiologist. It was a rare condition, usually caused by parvovirus or adenovirus. However, now I see two cases per day in the clinic. We have learned that COVID-19 can cause myocarditis. Various organizations, such as the Israeli and US military, as well as college leagues, conducted screening programs in 2020 and found a few cases, but none were serious or resulted in hospitalizations or deaths. These programs were later discontinued when vaccines were introduced. However, within six months, regulatory agencies confirmed that the COVID-19 vaccines can cause myocarditis, and it can be fatal. It's important for people to understand the risks associated with each vaccine dose they take.

A cardiologist provides an update on the Pfizer and Moderna vaccines. Studies have shown that the vaccines can cause direct harm to heart muscle cells, abnormal heart contractions, and abnormal electrical activity. Messenger RNA from the vaccines has been found in the human heart and circulating in the blood for up to 28 days. The spike protein produced by the messenger RNA has also been detected in the blood for up to 6 months. The spike protein is dangerous to cells, tissues, and organs in the body. The messenger RNA used in the vaccines has been modified and is synthetic. Autopsy studies have shown that the vaccine can cause myocarditis and cardiac damage. A basketball player who received the vaccine suffered a cardiac arrest and died two years later.

We have experience with this vaccine in a billion people, showing it is safe. The mRNA vaccine carries a very low risk of myocarditis, especially in young men. However, the risk of myocarditis from COVID is higher than from the vaccine.

In the question, myocarditis is discussed in relation to COVID-19. It has been mentioned for some time that infection with the novel coronavirus can lead to myocarditis, and that in some cases myocarditis can be severe or progress to myocarditis with structural complications. It is noted that myocarditis can also occur after vaccination, but the incidence is small and the symptoms are mild, with most people recovering. The speaker emphasizes that even when myocarditis occurs after vaccination, the risk is small and the condition tends to be mild. The statement asserts that almost all individuals recover from vaccine-associated myocarditis. Therefore, even if people who have received a vaccine develop myocarditis, the situation is not something to be alarmed about. The speaker argues that the benefits of vaccination far outweigh the risks, and that the idea of significant changes or issues related to the vaccine is not supported. The overall conclusion presented is that the risks of myocarditis, whether from infection or vaccination, are outweighed by the benefits of vaccination. Key points reiterated include: - COVID-19 infection can cause myocarditis, sometimes with considerable severity or with structural heart complications. - Myocarditis can also occur after vaccination, but the occurrence is rare and the symptoms are generally mild. - The vast majority of people with vaccine-associated myocarditis recover. - The perceived risk of myocarditis following vaccination should not be a cause for alarm, given that the benefits of vaccination are greater. - There is no indication that anything about the vaccine itself changes in a way that would alter this risk-benefit balance. Overall, the message is that myocarditis is a potential outcome associated with both infection and vaccination, but the frequency is low, the illness is typically mild, recovery is common, and vaccination remains advantageous.

The COVID-19 vaccine can induce cardiac arrest. mRNA injections travel to all organ systems, including the heart, causing cardiomyocytes to produce spike proteins, which are also found circulating in the bloodstream and can reach the heart. The largest COVID-19 vaccine safety study, involving 99 million people, showed a 600% increased risk of myocarditis after mRNA injections. The trigger for cardiac arrest is usually in the waking morning hours of sleep, 3AM to 6AM, or during sports or exercise when there's a surge in catecholamines. Cardiac events are known to occur during sleep when catecholamines rise and during exercise when oxygen demands and catecholamines increase. This is not supposed to be seen in young healthy adults, but rather in those with intrinsic heart disease or the very elderly.

The spike protein in the COVID-19 vaccines has been linked to four major domains of disease, including cardiovascular issues like heart inflammation and myocarditis. Regulatory agencies acknowledge the vaccine's association with myocarditis. As a cardiologist, I can confirm that people with myocarditis should not engage in strenuous activities as it can lead to cardiac arrest. However, sports leagues in Europe and the United States have been administering the vaccine to young individuals without medical necessity, resulting in numerous cases of cardiac arrest. Additionally, the vaccine has been proven to cause other cardiovascular diseases such as accelerated atherosclerosis and heart attacks, as well as posterior orthostatic tachycardia syndrome (POTS) leading to fainting due to low blood pressure. The vaccine is likely responsible for these issues until proven otherwise.

Before COVID-19, I only encountered two cases of myocarditis in my entire career as a cardiologist. It was a rare condition, usually caused by parvovirus or adenovirus. However, now I see two cases per day in the clinic. We have learned that COVID-19 can cause myocarditis. Various organizations, such as the Israeli and US military, as well as college leagues, conducted extensive screening programs for COVID-induced myocarditis in 2020. They found a few cases that met the definition, but none were serious or resulted in hospitalizations or deaths. These screening programs were later discontinued when vaccines were introduced. However, within six months, regulatory agencies confirmed that the COVID-19 vaccines can cause myocarditis. It is important for people to understand that there is a risk of vaccine-induced myocarditis with every shot they take.

Dr. Peter Mercola, a cardiologist and chief scientific officer, discusses the negative effects of the COVID vaccine. Recent studies have shown that messenger RNA is found directly in the human heart, causing inflammation known as myocarditis. Another study revealed that the vaccine changes the heart's preference from fatty acids to glucose. Additionally, both Pfizer and Moderna vaccines applied directly to heart muscle cells caused abnormal contractions and depolarization of electrical currents. These findings suggest that the vaccines not only cause myocarditis but may also lead to a metabolic cardiomyopathy, potentially explaining sudden cardiac death without myocarditis. The rise in these issues is concerning.

"Unfortunately, the mRNA platform, though it is brilliant in its conception, is fatally flawed." "the myocarditis and pericarditis that showed up as a result of COVID vaccinations are inherent to the platform, not to the messenger RNA that was delivered inside these shots." "the design of this platform is to induce your own cells to make a foreign protein which gets displayed on the surface of those cells." "there's no targeting mechanism to lead it to happen only in certain tissues, it can happen haphazardly around the body, including in places like your heart." "And what that triggers is your own immune system to see those foreign proteins and conclude the only thing they can, which is that those cells have been virally infected." "the right response, the response, the natural response of the body is to take virally infected cells and destroy them."

The CDC safety group has found a link between the COVID-19 vaccine and heart conditions in young adults. Reports of chest pain, fluttering, and inflammation around the heart have been investigated by the CDC. These side effects, known as myocarditis, can cause fast pains and shortness of breath. The Canadian Foodiatric Society also recognizes myocarditis as a potential side effect of the vaccine.

Myocarditis, or heart inflammation, is more common than previously believed. Recent studies show that around 20% of individuals who received the COVID vaccine experience myocarditis, as confirmed by echocardiograms and other tests. This means that out of every 1 million vaccinated people, around 200,000 will have evidence of heart damage. Unfortunately, those who develop myocarditis have a 50% chance of surviving only 5 years. This alarming increase in myocarditis cases is due to the cardiotoxic nature of the vaccine. These facts, shared by Dr. Cussell and Shoemaker from Toronto, highlight the concerning impact of the vaccine on heart health.

The spike protein from the COVID-19 virus circulates in the body and can land in multiple organs, causing various diseases. Lab studies have shown that even without the virus, just injecting the spike protein can induce the same lung, vascular, heart, and brain diseases as COVID-19. The spike protein is considered the toxin responsible for causing the disease. This raises questions about why we are injecting something that is essentially a toxin into the human body, as it is not a traditional vaccine.

Before COVID-19, I only encountered two cases of myocarditis in my entire career as a cardiologist. However, now I see two cases per day in the clinic. We have learned that COVID-19 can cause myocarditis, and various organizations conducted screening programs in 2020. These programs found a few cases that met the definition of myocarditis, but none were serious or resulted in hospitalizations or deaths. After the introduction of vaccines, regulatory agencies acknowledged that the vaccines can cause COVID-19 vaccine-induced myocarditis, which can be fatal. It's important for people to understand that there is a risk associated with every vaccine shot they take.

Vaccination introduces mRNA into the bloodstream, which is taken up by major organs, including the heart. This process leads to the production of spike protein in heart muscle cells, resulting in inflammation and an increased risk of myocarditis. A large study indicated a 500% higher risk of myocarditis following COVID vaccination. Symptoms of myocarditis can be triggered during early morning hours (3 AM to 6 AM) when catecholamines like dopamine and epinephrine surge, as well as during exercise. These triggers can lead to serious heart issues, including ventricular tachycardia and sudden death.

In October 2020, the FDA mentioned that myocarditis could be a result of the COVID vaccines. In June 2021, the FDA confirmed that the vaccines can cause heart inflammation. Prior to COVID, patients with myocarditis were advised not to exercise due to the risk of cardiac arrest. Now, there are 800 peer-reviewed papers on COVID vaccine-induced myocarditis. Two studies showed a 2.5% rate of heart damage after receiving the second or third vaccine dose. When heart damage occurs, there can be variations in electrical conduction, leading to reentry and fast heart rhythms like ventricular tachycardia. This can progress to ventricular fibrillation, which is fatal. A recent study confirmed that vaccine-induced myocarditis is always fatal.

First, the mRNA is injected within lipid nanoparticles in your arm. It travels through every organ system, including the heart. Crosson found mRNA directly in the heart of deceased mRNA recipients. So we know it reaches the heart. Baumeyer found the spike protein directly in the heart in biopsies of patients with vaccine induced myocarditis. So we know the vaccine mRNA and lipid nanoparticles get into the heart, translate into spike proteins, so your cardiomyocytes begin to produce a toxic non human protein and your own body attacks the heart resulting in inflammation and cardiac scarring including micro scars which are undetectable with imaging. And so once you have this scarring, you're going to have cardiac electrical abnormalities, electrical conduction abnormalities, and your heart's not going to beat properly. And that's why we saw a lot of sudden deaths among athletes back in 2021.

The harm caused by this vaccine isn't from the spike protein itself, but from the immune system's misidentification of the heart. The body attacks the heart because the spike protein alters its genetic image, making it seem foreign. This is fundamental immunology. The vaccine's creators were aware of this effect. The vaccine's toxicity and ability to manipulate the immune system to cause harm, whether slowly or rapidly, point to a deliberate design. This level of damage couldn't be accidental.